Stockreport

Neurocode Launches Groundbreaking pTau217 Blood Test for Alzheimer's Disease Clinical Diagnosis [Yahoo! Finance]

Quanterix Corporation  (QTRX) 
US:NASDAQ Investor Relations: ir.quanterix.com/investor-relations
PDF for neurological disorders, is pleased to announce the clinical launch of ALZpath Dx , an innovative and novel blood test that can be used in the screening, diagnosis, a [Read more]